OBALON THERAPEUTICS INC

Profile

Company Names

OBALON THERAPEUTICS INC

Addresses

5421 AVENIDA ENCINAS, SUITE F, CARLSBAD, CA 92008

5421 AVENIDA ENCINAS, SUITE F, CARLSBAD, CA 92008

5421 AVENIDA ENCINAS, SUITE F, SAN DIEGO, CA 92008

Phone Numbers

(760) 795-6558
858-480-2400
760-795-6557

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2008

State Incorporated:

DELAWARE

Total Amount Raised:

$48,923,012.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2018-08-23 
$10,000,000.00 
$10,000,000.00 
$0.00 
Equity 
4
2014-08-28 
$15,899,998.00 
$30,000,005.00 
$14,100,007.00 
Equity 
3
2012-12-14 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity 
2
2012-05-04 
$16,523,014.00 
$16,525,000.00 
$1,986.00 
Equity 
1
2012-02-24 
$1,500,000.00 
$1,500,000.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MARK 
 
BRISTER 
EXECUTIVE OFFICER
RAYMOND 
 
DITTAMORE 
DIRECTOR
DOUG 
 
FISHER 
DIRECTOR
DOUGLAS 
 
FISHER 
DIRECTOR
LES 
 
HOWE 
DIRECTOR
KELLY 
 
HUANG, PH.D. 
EXECUTIVE OFFICER
KIM 
PULOMA 
KAMDAR 
DIRECTOR, EXECUTIVE OFFICER
KIM 
 
KAMDAR, PH.D. 
DIRECTOR
DAVID 
 
MOATAZEDI 
DIRECTOR
WILLIAM 
J. 
PLOVANIC 
EXECUTIVE OFFICER
ANDREW 
 
RASDAL 
EXECUTIVE OFFICER, DIRECTOR
DOUGLAS C. 
 
SAMPSON 
DIRECTOR
SHARON 
 
STEVENSON 
DIRECTOR
SHARON 
 
STEVENSON, DVM PH.D. 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2018-08-23 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-08-28 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-12-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-05-04 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-02-24 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#